IDEAYA Biosciences (IDYA) Misses Q1 EPS by 2c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q1 EPS of ($0.53), $0.02 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• RH (RH) Tops Q2 EPS by $2.31
• UBS Downgrades Nuscale Power (SMR) to Sell